These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6602955)

  • 41. Effects of blood transfusion on cellular immunity.
    Giacchino F; Belardi P; Coppo R; Quarello F; Alloatti S; Pozzato M; Giraudo G; Roccatello D; Basolo B; Boero R; Piccoli G
    Proc Eur Dial Transplant Assoc; 1981; 18():465-8. PubMed ID: 7036167
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction between antibiotics and non-specific humoral immunity.
    Minelli EB; Miglioli PA; Beghini AM; Panzetta G; Berti T
    J Chemother; 1989 Jul; 1(4 Suppl):417-8. PubMed ID: 16312465
    [No Abstract]   [Full Text] [Related]  

  • 43. [Pseudo-porphyria cutanea tarda in patients hemodialyzed for chronic renal insufficiency. Clinical, metabolic and immunological aspects].
    Cogoni G; Aste N; Cengiarotti L; Loy M; Demelia L; Martinelli V; Biggio P
    Minerva Nefrol; 1982; 29(4):195-203. PubMed ID: 6984147
    [No Abstract]   [Full Text] [Related]  

  • 44. [Immunologic disorders in uremia].
    Górski A
    Pol Tyg Lek; 1987 Oct; 42(42):1322-3. PubMed ID: 3502180
    [No Abstract]   [Full Text] [Related]  

  • 45. Some aspects of cellular immunity in untreated and maintenance hemodialysis patients.
    Hanicki Z; Cichocki T; Komorowska Z; Sułowicz W; Smoleński O
    Nephron; 1979; 23(6):273-5. PubMed ID: 481664
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diminished chemokine and cytokine-induced adhesion of CD4+ T cells to extracellular matrix ligands in patients with end-stage renal failure.
    Zeltzer E; Bernheim J; Korzets Z; Zeeli D; Rathaus M; Mekori YA; Hershkoviz R
    Isr Med Assoc J; 2000 Apr; 2(4):282-6. PubMed ID: 10804903
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interferon production by leucocytes of dialysed chronic uraemic patients.
    Gál G; Toth M; Toth S
    Proc Eur Dial Transplant Assoc; 1981; 18():188-92. PubMed ID: 6173878
    [No Abstract]   [Full Text] [Related]  

  • 48. Cell-mediated immune alterations in uraemics before and after haemodialysis.
    Saha K; Gulati PD; Sharma RK; Rizvi SN
    J Indian Med Assoc; 1981 Feb; 76(3):36-41. PubMed ID: 7252209
    [No Abstract]   [Full Text] [Related]  

  • 49. Mechanisms of neutrophil apoptosis in uremia and relevance of the Fas (APO-1, CD95)/Fas ligand system.
    Jaber BL; Perianayagam MC; Balakrishnan VS; King AJ; Pereira BJ
    J Leukoc Biol; 2001 Jun; 69(6):1006-12. PubMed ID: 11404388
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The inhibitory influence of dialysis treatment on E-rosette formation.
    Giacchino F; Alloatti S; Belardi P; Coppo R; Giraudo G; Bosticardo GM; Pozzato M; Piccoli G
    Trans Am Soc Artif Intern Organs; 1982; 28():594-8. PubMed ID: 7164309
    [No Abstract]   [Full Text] [Related]  

  • 51. Renal function influences interleukin-8 background production by cultured human mesothelial cells.
    Visser CE; Brouwer-Steenbergen JJ; Postmus PE; Meijer S; Struijk DG; Krediet RT; Beelen RH
    Adv Perit Dial; 1996; 12():15-8. PubMed ID: 8865864
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of zinc supplementation in chronic haemodialysis patients.
    Bonomini M; Di Paolo B; De Risio F; Niri L; Klinkmann H; Ivanovich P; Albertazzi A
    Nephrol Dial Transplant; 1993; 8(10):1166-8. PubMed ID: 8272232
    [No Abstract]   [Full Text] [Related]  

  • 53. [Features of cellular immunity of chronic lympholeukemia].
    Sinitsina AM; Zverkova AS
    Vrach Delo; 1982; (10):49-51. PubMed ID: 6983781
    [No Abstract]   [Full Text] [Related]  

  • 54. [Platelet adhesiveness and drip rate during extracorporeal dialysis in uremia].
    Cortellaro M; Brancaccio D
    Haematol Lat; 1968; 11(2):189-97. PubMed ID: 5697768
    [No Abstract]   [Full Text] [Related]  

  • 55. [Acid-base equilibrium in uremia: effect of continuous ambulatory peritoneal dialysis and hemodialysis].
    Nin Ferrari J; Santoro A; Fabbri L; Cavilli F; Zucchelli P
    G Clin Med; 1981 Sep; 62(9):624-33. PubMed ID: 7319174
    [No Abstract]   [Full Text] [Related]  

  • 56. Host immune status in uraemia. II. Serum factors and lymphocyte transformation.
    Stewart E; Miller TE
    Clin Exp Immunol; 1980 Jul; 41(1):123-9. PubMed ID: 6969146
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Confirmation of delayed sensitivity in uremia].
    Croce J; Sabbaga E; Chocair PR
    AMB Rev Assoc Med Bras; 1971 Aug; 17(8):283-4. PubMed ID: 5316373
    [No Abstract]   [Full Text] [Related]  

  • 58. Iodine and thyroid dysfunction in uremia.
    Monzani F; Panichi V; De Negri F; Del Guerra P; Bartalena L; Pacchiarotti A; Palla R; Pinchera A; Baschieri L
    Clin Nephrol; 1990 Jul; 34(1):44. PubMed ID: 2387104
    [No Abstract]   [Full Text] [Related]  

  • 59. [Alloantigens of subpopulations of T lymphocytes in uremic patients with chronic glomerulonephritis].
    Adorno D; Irti T; Papola F; Piazza A; Spagnoli G; Valeri M; Casciani CU
    Minerva Nefrol; 1981; 28(3):187-93. PubMed ID: 6977105
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of vaccination schedule and dialysis on hepatitis B vaccination response in uraemic patients.
    Bommer J; Ritz E; Andrassy K; Bommer G; Deinhardt F; Jilg W; Darai G
    Proc Eur Dial Transplant Assoc; 1983; 20():161-8. PubMed ID: 6657651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.